G01N 2333/4722
Proteoglycans
Official title: Proteoglycans, e.g. aggreccan
G01N2333/4722 (Proteoglycans) appears on 52 US grants and 114 published applications in this corpus.
Search patents in G01N- Granted patents
- 52
- Published applications
- 114
- Assignees
- 89
- Inventors
- 284
- Latest grant
- 19 May 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 2 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 0 | 2 |
| 2003 | 0 | 1 |
| 2004 | 0 | 0 |
| 2005 | 0 | 1 |
| 2006 | 3 | 6 |
| 2007 | 0 | 2 |
| 2008 | 0 | 4 |
| 2009 | 2 | 8 |
| 2010 | 0 | 6 |
| 2011 | 4 | 2 |
| 2012 | 2 | 5 |
| 2013 | 3 | 8 |
| 2014 | 4 | 3 |
| 2015 | 2 | 9 |
| 2016 | 5 | 8 |
| 2017 | 2 | 6 |
| 2018 | 3 | 6 |
| 2019 | 6 | 4 |
| 2020 | 3 | 3 |
| 2021 | 4 | 5 |
| 2022 | 1 | 4 |
| 2023 | 0 | 5 |
| 2024 | 1 | 7 |
| 2025 | 1 | 6 |
| 2026 | 2 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Peptidoglycan (PGN) aptamers and associated methods19 May 2026US 12,631,636 B2Fresenius Medical Care Holdings, Inc.
- Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of Lyme disease-related pathologies27 Jan 2026US 12,535,481 B2Virginia Tech Intellectual Properties, Inc.
- Diagnosis method of multiple sclerosis18 Mar 2025US 12,253,530 B2Centre Hospitalier Universitaire De Nimes
- Methods and devices for quantitatively estimating syndecan-11 Oct 2024US 12,105,099 B2Diotex Diagnostics, LLC
- Anti-human migration stimulating factor (MSF) and uses thereof22 Feb 2022US 11,254,739 B2Humanitas Mirasole S.P.A.
- Biomarker of skin aging, method for determining skin aging, and method for screening substance for improving skin aging3 Sep 2026US 2026/0259224 A1Rohto Pharmaceutical Co., Ltd.
- Peptide compositions targeting glypican-3 and uses thereof27 Aug 2026US 2026/0248930 A1PeptiDream Inc.
- Borrelia burgdorferi peptidoglycan as a diagnostic and target for therapeutic intervention of lyme disease-related pathologies4 Jun 2026US 2026/0153509 A1Virginia Tech Intellectual Properties, Inc.
- Application of biomarker in preparing metabolic dysfunction-associated steatotic liver disease classification products4 Dec 2025US 2025/0369986 A1Chengdu Seventh People's Hospital
- Tropnin marker combinations for early discrimination of type 2 versus type 1 acute myocardial infarction27 Nov 2025US 2025/0362308 A1Roche Diagnostics Operations, Inc.
Most cited
By later US patents
- Methods and compositions for diagnosing and treating arthritic disorders and regulating bone mass35US 7,005,274 B1Migenix Inc. · 2006
- Method and measurement kit for assay of normal agrecan, and method for evaluation of informations on the joint32US 5,948,692 ASeikagaku Corporation · 1999
- Reagents for determining peptidoglycan and .beta.-1,3-glucan26US 4,970,152 AWako Pure Chemical Industries, Ltd. · 1990
- Methods and compositions for detection of microbial contaminants in peritoneal dialysis solution22US 7,618,392 B2Baxter Healthcare S. A. · 2009
- Methods and compositions for detection of microbial contaminants in peritoneal dialysis solutions9US 7,118,857 B2Baxter Healthcare S. A. · 2006